A selective small-molecule inhibitor of c-Met suppresses keloid fibroblast growth in vitro and in a mouse model
Abstract Keloids, tumor-like lesions that result from excessive scar formation, have no definitive treatment modality. Activation of c-mesenchymal-epithelial transition factor (c-Met) promotes cell proliferation and survival. Selective c-Met inhibitors, such as PHA-665752, may attenuate the activity...
Guardado en:
Autores principales: | Min-Ha Choi, Jinhyun Kim, Jeong Hyun Ha, Ji-Ung Park |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/41156ac7718940f690f028338fcefc8a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparison of Primary Keloid Fibroblast Cultivation Methods and the Characteristics of Fibroblasts Cultured from Keloids, Keloid-surrounding Tissues, and Normal Skin Tissues
por: Qin,Haiyan, et al.
Publicado: (2021) -
Mortalin deficiency suppresses fibrosis and induces apoptosis in keloid spheroids
por: Won Jai Lee, et al.
Publicado: (2017) -
Small-Molecule Inhibitors and Degraders Targeting KRAS-Driven Cancers
por: Soonsil Hyun, et al.
Publicado: (2021) -
MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitors
por: Lun-Xi Peng, et al.
Publicado: (2021) -
The combination of the tubulin binding small molecule PTC596 and proteasome inhibitors suppresses the growth of myeloma cells
por: Yurie Nagai, et al.
Publicado: (2021)